MARKETS & MATERIALS
Data & sources →

Top 25 issuers by reported market capitalization in The Weekly 250. Prices: 2 Oct 2026 close. Changes: versus 2026-09-25; not live.

Saved observations · connecting · Update schedule

THE GLOBAL FINANCIAL WEEKLYSeptember 28–October 4, 2026Vol. 01 · No. 001
THE WORLD AT A GLANCE

World markets

Dated source observations

Financial centers · Natural Earth

S&P 5007,722.72

index points ·

EUR / USD 1.12045 Oct 2026 · USD per EUR

Saved observations · connecting · Update schedule

Dated observations · not live quotes
How to read this map

Currency cross-rates show local-currency units per U.S. dollar, calculated from the same ECB euro reference snapshot. The U.S. card leads with a dated S&P500 index close and shows USD per EUR beneath. Pins locate financial centers; currency references are not exchange-specific prices.

Choose a region with the arrow keys, then use the Market selector. Policy settings and equity-index levels retain their own dates. Shading shows the selected region, not market performance.

All observations, definitions & sources →
News / All topics / M&A + Buy/Sell Signaling

TOPIC NEWS · September 28–October 4, 2026

M&A + Buy/Sell Signaling

World Labs agreement and a contingent healthcare buyout show why deal terms matter as much as headline values.

M&A + Buy/Sell Signaling

Lifecore common-share consideration

USD per common equivalent

03.146.286.28Cash at closing3.39Potential CVR increment
Issuer illustration: potential combined amount up to $9.67; CVR increment is contingent and non-tradable, not current cash or fair value.

Sources: [3] Lifecore: Agreement with Webster Equity Partners · 2026-09-28

AMD Makes an $8.2 Billion Bet on Model Research

World Labs agreement and a contingent healthcare buyout show why deal terms matter as much as headline values.

Read the report →

M&A + Buy/Sell Signaling PREMIUM

Lifecore common-share consideration

USD per common equivalent

03.146.286.28Cash at closing3.39Potential CVR increment
Issuer illustration: potential combined amount up to $9.67; CVR increment is contingent and non-tradable, not current cash or fair value.

Sources: [3] Lifecore: Agreement with Webster Equity Partners · 2026-09-28

Separate the Deal Price from the Deal Outcome

World Labs agreement and a contingent healthcare buyout show why deal terms matter as much as headline values.

Read premium analysis →